A controlled clinical study of modified internal limiting membrane peeling in the treatment of myopia foveoschisis

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200060265

Enrollment

Unknown

Registered

2022-05-24

Start date

2018-10-31

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia foveoschisis

Interventions

TA Group:TA assisted to peel ILM

ICG Group:ICG assisted to peel ILM

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Eyeshaft length >= 26 mm; 2. In the past six months, there have been symptoms of significant visual impairment or visual deformation in the patient; 3. The diagnosis of high myopia with macular splitting by optical coherence tomography (OCT) includes lamellar splitting of the retina at the fovea, with or without an increase in central retinal thickness (CRT), macular anterior membrane, and macular lamellar holes.

Exclusion criteria

Exclusion criteria: 1. Those who suffer from severe cardiovascular and cerebrovascular diseases, severe liver and kidney dysfunction, and other serious systemic diseases, and cannot tolerate microsurgical surgery; 2. After vitrectomy; 3. Serious eye injury; 4. Active uveitis; 5. Uncontrolled glaucoma; 6. Severe corneal leukoplakia.

Design outcomes

Primary

Measure	Time frame
Visual acuity;MF recovery situation;Central retinal thickness;operation styles selection;	—

Countries

China

Contacts

Public ContactDuan Yiqin

Aier Eye Hospital Group Changsha Aier Eye Hospital

duanyiqin@aierchina.com+86 15874059961

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026